Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study

By H. Ibsen, M. Olsen, K. Wachtell, K. Borch-Johnsen, L. Lindholm, C. Mogensen, B. Dahlöf, R. Devereux, U. de Faire, F. Fyhrquist and 7 more. HYPERTENSION, 2005

605 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nephrology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/a3d4f00854dca0d1e0993584988275d9f653004e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Laurent
2. M. Woodward
3. H. S. Boudier
4. Massimo F. Piepoli
5. V. Basevi
6. B. K. Pedersen
7. B. Saltin

Citations in the corpus

• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “Recent post hoc analyses of clinical trials, however, have found that the albumin–creatinine ratio is a reasonablemethod to assess change over time (357).”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “Recent post hoc analyses of clinical trials, however, have found that the albumin–creatinine ratio is a reasonablemethod to assess change over time (357).”
• Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009, background): “Previous vascular disease (n % ) history of macrovascular disease 3394 (32) history of myocardial infarction 1250 (12) history of stroke 971 (9) Other major risk factors HbA1c (%; mean SD ) 7.”
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Lower incidence of CV events and slower progression of renal disease have also been repeatedly associated with treatment-induced reduction in urinary protein excretion in both diabetic and nondiabetic patients [227,262,535,536,687,688] but, especially for microalbuminuria, discordant results have al”